Dr. Vries joins the monthly seminar series organized by the Personalized Health Basel (PHB) initiative.

Personalized medicine holds great promise for the future of patient treatment, offering the opportunity to refine our understanding of risk/benefits of a new treatment and identify subsets of patients that are more likely to respond based on pharmacogenomic data.


Have any questions?

contact us